To determine whether FDXR is directly regulated by p53 in liver cells, we used CRISPR/Cas9 to generate p53-knockout (KO) HepG2 and SK-HEP-1 cell lines, derived from human hepatocellular carcinoma (Fig. 1c, 1d). The gene discussed is FDXR; the disease is hepatocellular carcinoma.